68P Phase II results of ivonescimab (ivo) a novel PD-1/VEGF bispecific in combination with chemotherapy for first-line treatment of patients (pts) with advanced/metastatic squamous (Sq) non-small cell lung cancer (NSCLC)
Authors:
- L. ZhangLZL. Zhang
- W.F. FangWFW.F. Fang
- Y. ZhaoYZY. Zhao
- Y. YangYYY. Yang
- N. ZhouNZN. Zhou
- L. ChenLCL. Chen
- Y. HuangYHY. Huang
- J. ChenJCJ. Chen
- L. ZhuangLZL. Zhuang
- Y. DuYDY. Du
- Q. YuQYQ. Yu
- W. ZhuangWZW. Zhuang
Open Access